Synergy stent for treating unprotected left main stenosis with the large reference vessel diameter
Wen-Long XING
Hong-Xu LIU
Ai-Yong LI
Qi ZHOU
Da-Wei ZHANG
Chiung-Jen WU
Wei TIAN
Teng-Fei LI
Zi-Hao LIU
摘要：For many years,tmprotected left main stenosis (ULMS)has been remained as the forbidden fruit of interventional cardiology.However,with the remarkable improvement in medical device technology,procedural techniques and antithrombotic agents during the last decades,percutaneous coronary intervention (PCI) with stenting for ULMS has become technically feasible and has exhibited favorable clinical outcomes.In particular,the development of drug-eluting stents (DES) has played an important role.Extensive studies in the DES era,from SYNTAX,[1] EXCEL[2] to NOBEL,[3]have confirmed its safety and efficacy,which is similar to those observed with coronary artery bypass grafting (CABG),at least for patients without very diffuse disease in other coronary segments.Furthermore,a study conducted in 2015 was the first to report that interventional therapy of ULMS is also effective and safe for the elderly patients.
机标关键词：
论文发表日期：2020-06-28
页数：8( 365-372 )
英文信息